DXCM DexCom, Inc.

80.19USD-2.82%Mkt Cap: 29.91B USDP/E: 31.57

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap29.91B USD
Enterprise Value30.35B USD
Revenue (TTM)5.10B USD
Gross Profit2.80B USD
Net Income (TTM)836.30M USD
Revenue/Share13.36 USD
Last Price80.19 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)31.57
P/E (Forward)25.58
PEG1.30
EV/EBITDA20.25
EV/Revenue5.95
P/S5.86
P/B11.80
EPS (TTM)2.55 USD
EPS (Forward)3.13 USD
52W Range
54.1168% of range92.59
52W High92.59 USD
52W Low54.11 USD
Profitability
Gross Margin60.10%
Oper. Margin23.97%
EBITDA Margin29.36%
Profit Margin17.94%
ROE30.46%
ROA13.19%
ROIC32.78%
ROCE21.72%
Growth
Revenue Growth11.20%
Earnings Growth2.60%
Cash Flow & Leverage
Operating CF1.44B USD
CapEx (TTM)363.50M USD
FCF Margin15.91%
FCF Yield2.71%
Net Debt-425.00M USD
Net Debt/EBITDA-0.28
Net Debt/FCF-0.52
Balance Sheet
Debt/Equity0.51
Current Ratio1.74
Quick Ratio1.34
Book Value/Sh6.80 USD
Cash/Share4.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)98.58 USD
Upside (mean)+22.9%
Target Range79.00 USD – 120.00 USD
79.00+22.9% to mean120.00
# Analysts26
Ownership
Shares Out.372.95M
Float371.59M
Insiders0.26%
Institutions104.71%
Short Interest
Short Ratio3.5d
Short % Float4.94%
Short % Out.4.27%
Shares Short15.93M
Short (prev mo.)14.02M
Technical
SMA 5084.17 (-4.7%)
SMA 20075.12 (+6.7%)
Beta1.44
S&P 52W Chg12.08%
Avg Vol (30d)4.58M
Avg Vol (10d)4.01M
Technical Indicators
RSI (14)45.1
MACD-0.5860
MACD Signal-0.6594
MACD Hist.+0.0734
BB Upper86.58 USD
BB Middle81.42 USD
BB Lower76.27 USD
BB Width12.66%
ATR (14)2.829 USD
Vol Ratio (20d)0.90x

About DexCom (NASDAQ: DXCM)

›

DexCom (NASDAQ: DXCM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 11,000 employees.

The shares were at 80.19 USD on 19 November 2026, up 38.2% over 52 weeks. Its 52-week range is 54.11 USD to 92.59 USD: the price is 13.4% below the high and 48.2% above the low.

At a market capitalisation of 29.91B USD, it trades at 31.6 times trailing earnings and 25.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.4, a premium of 24% for DXCM.

DexCom reports return on equity of 30.5%, an operating margin of 24.0% and revenue up 11.2% year over year.

It holds more cash than debt, a net cash position of 425.00M USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 26 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 98.58 USD is 22.9% above the current price. The next earnings report is expected on 11 February 2027.